These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10489873)

  • 21. Longitudinal PET/CT evaluation of TNBS-induced inflammatory bowel disease rat model.
    Seoane-Viaño I; Gómez-Lado N; Lázare-Iglesias H; Barreiro-de Acosta M; Silva-Rodríguez J; Luzardo-Álvarez A; Herranz M; Otero-Espinar F; Antúnez-López JR; Lamas MJ; Aguiar P; Fernández-Ferreiro A; Ruibal Á
    Int J Pharm; 2018 Oct; 549(1-2):335-342. PubMed ID: 30081226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of tranilast on experimental colitis in rats.
    Seto Y; Kato K; Tsukada R; Suzuki H; Kaneko Y; Kojo Y; Sato H; Onoue S
    Biomed Pharmacother; 2017 Jun; 90():842-849. PubMed ID: 28437888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of zileuton, a new 5-lipoxygenase inhibitor, in experimentally induced colitis in rats.
    Zingarelli B; Squadrito F; Graziani P; Camerini R; Caputi AP
    Agents Actions; 1993 Jul; 39(3-4):150-6. PubMed ID: 7905704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway.
    Zeng Z; Zhan L; Liao H; Chen L; Lv X
    Planta Med; 2013 Jan; 79(2):102-9. PubMed ID: 23250811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated measurement of intestinal permeability as an assessment of colitis severity in HLA-B27 transgenic rats.
    Kerr SW; Wolyniec WW; Filipovic Z; Nodop SG; Braza F; Winquist RJ; Noonan TC
    J Pharmacol Exp Ther; 1999 Nov; 291(2):903-10. PubMed ID: 10525115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental evidence of heparanase, Hsp70 and NF-κB gene expression on the response of anti-inflammatory drugs in TNBS-induced colonic inflammation.
    Quaglio AE; Castilho AC; Di Stasi LC
    Life Sci; 2015 Nov; 141():179-87. PubMed ID: 26434698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-inflammatory and antibacterial effects of human cathelicidin active fragment KR-12 in the mouse models of colitis: a novel potential therapy of inflammatory bowel diseases.
    Fabisiak N; Fabisiak A; Chmielowiec-Korzeniowska A; Tymczyna L; Kamysz W; Kordek R; Bauer M; Kamysz E; Fichna J
    Pharmacol Rep; 2021 Feb; 73(1):163-171. PubMed ID: 33219923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of nimesulide on acetic acid- and leukotriene-induced inflammatory bowel disease in rats.
    Singh VP; Patil CS; Jain NK; Singh A; Kulkarni SK
    Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):163-75. PubMed ID: 14518559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiological studies of trinitrobenzene sulfonic acid-induced colitis in Syrian hamsters (Mesocricetus auratus).
    Hirota Y; Suzuki M; Yamaguchi K; Fujita T; Katsube N
    Comp Med; 2005 Feb; 55(1):45-54. PubMed ID: 15766209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effect of trimebutine and N-monodesmethyl trimebutine on trinitrobenzene sulfonic acid-induced colitis in rats.
    Chevalier E; Pétoux F; Chovet M; Langlois A
    Life Sci; 2004 Dec; 76(3):319-29. PubMed ID: 15531383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B.
    Liu QQ; Wang HL; Chen K; Wang SB; Xu Y; Ye Q; Sun YW
    J Dig Dis; 2016 Feb; 17(2):104-12. PubMed ID: 26718746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression and variability of TNBS colitis-associated inflammation in rats assessed by contrast-enhanced and T2-weighted MRI.
    Pohlmann A; Tilling LC; Robinson A; Woolmer O; McCleary S; Kruidenier L; Warnock LC; Lewis HD; Hobson AR; James MF
    Inflamm Bowel Dis; 2009 Apr; 15(4):534-45. PubMed ID: 19058230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of different doses of Manuka honey in experimentally induced inflammatory bowel disease in rats.
    Prakash A; Medhi B; Avti PK; Saikia UN; Pandhi P; Khanduja KL
    Phytother Res; 2008 Nov; 22(11):1511-9. PubMed ID: 18688794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Taurine can ameliorate inflammatory bowel disease in rats.
    Son M; Ko JI; Kim WB; Kang HK; Kim BK
    Adv Exp Med Biol; 1998; 442():291-8. PubMed ID: 9635044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-ASA-glutamate protects rats from inflammatory bowel disease induced by intracolonic administration of trinitrobenzensulfonic acid.
    Clerici C; Gentili G; Pellicciari R; Gresele P; Mezzasoma AM; Giansanti M; Clementi M; Bartoli G; Balò S; Modesto R; Aburbeh AG; Morelli O; Morelli A
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):385-90. PubMed ID: 9789134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of Pim-1 inhibitor on mouse model of inflammatory bowel disease induced by TNBS].
    Ou R; Shen Y; Zeng Y; Zou L; Jiang N; Xu M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 May; 43(5):481-489. PubMed ID: 29886462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy.
    Karrout Y; Dubuquoy L; Piveteau C; Siepmann F; Moussa E; Wils D; Beghyn T; Neut C; Flament MP; Guerin-Deremaux L; Dubreuil L; Deprez B; Desreumaux P; Siepmann J
    J Control Release; 2015 Jan; 197():121-30. PubMed ID: 25445696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Inflammatory Local Effect of Hydroxytyrosol Combined with Pectin-Alginate and Olive Oil on Trinitrobenzene Sulfonic Acid-Induced Colitis in Wistar Rats.
    Voltes A; Bermúdez A; Rodríguez-Gutiérrez G; Reyes ML; Olano C; Fernández-Bolaños J; Portilla F
    J Invest Surg; 2020 Jan; 33(1):8-14. PubMed ID: 29764253
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease.
    Peterson RL; Wang L; Albert L; Keith JC; Dorner AJ
    Lab Invest; 1998 Dec; 78(12):1503-12. PubMed ID: 9881950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.